AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

被引：955
作者：
Rinella, Mary E. [1 ,9 ]
Neuschwander-Tetri, Brent A. [2 ]
Siddiqui, Mohammad Shadab [3 ]
Abdelmalek, Manal F. [4 ]
Caldwell, Stephen [5 ]
Barb, Diana [6 ]
Kleiner, David E. [7 ]
Loomba, Rohit [8 ]
机构：
[1] Univ Chicago Pritzker, Sch Med, Chicago, IL USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
[3] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Virginia, Sch Med, Charlottesville, VA USA
[6] Univ Florida, Coll Med, Gainesville, FL USA
[7] NCI, Bethesda, MD USA
[8] Univ Calif San Diego, San Diego, CA USA
[9] Univ Chicago, Pritzker Sch Med Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
MAGNETIC-RESONANCE ELASTOGRAPHY; TYPE-2; DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; OBSTRUCTIVE SLEEP-APNEA; ACCURATELY IDENTIFIES PATIENTS; PEPTIDE-1 RECEPTOR AGONISTS; ADIPOSE-TISSUE DISTRIBUTION; MORBIDLY OBESE-PATIENTS; POST-HOC ANALYSIS; HEPATIC STEATOSIS;
D O I：
10.1097/HEP.0000000000000323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1797 / 1835
页数：39
相关论文
共 491 条
  • [31] Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
    Athyros, Vasilios G.
    Tziomalos, Konstantinos
    Gossios, Thomas D.
    Griva, Theodora
    Anagnostis, Panagiotis
    Kargiotis, Konstantinos
    Pagourelias, Efstathios D.
    Theocharidou, Eleni
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    [J]. LANCET, 2010, 376 (9756) : 1916 - 1922
  • [32] A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
    Awazawa, Motoharu
    Gabel, Paula
    Tsaousidou, Eva
    Nolte, Hendrik
    Krueger, Marcus
    Schmitz, Joel
    Ackermann, P. Justus
    Brandt, Claus
    Altmueller, Janine
    Motameny, Susanne
    Wunderlich, F. Thomas
    Kornfeld, Jan-Wilhelm
    Blueher, Matthias
    Bruning, Jens C.
    [J]. NATURE MEDICINE, 2017, 23 (12) : 1466 - +
  • [33] Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease
    Azzu, Vian
    Vacca, Michele
    Virtue, Samuel
    Allison, Michael E. D.
    Vidal-Puig, Antonio
    [J]. GASTROENTEROLOGY, 2020, 158 (07) : 1899 - 1912
  • [34] Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults
    Bae, Ji Cheol
    Suh, Sunghwan
    Park, Se Eun
    Rhee, Eun Jung
    Park, Cheol Young
    Oh, Ki Won
    Park, Sung Woo
    Kim, Sun Woo
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    Lee, Myung-Shik
    Lee, Moon Kyu
    Kim, Kwang-Won
    Lee, Won-Young
    [J]. PLOS ONE, 2012, 7 (10):
  • [35] Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
    Ballestri, Stefano
    Zona, Stefano
    Targher, Giovanni
    Romagnoli, Dante
    Baldelli, Enrica
    Nascimbeni, Fabio
    Roverato, Alberto
    Guaraldi, Giovanni
    Lonardo, Amedeo
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) : 936 - 944
  • [36] Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study
    Bano, Arjola
    Chaker, Layal
    Plompen, Elisabeth P. C.
    Hofman, Albert
    Dehghan, Abbas
    Franco, Oscar H.
    Janssen, Harry L. A.
    Murad, Sarwa Darwish
    Peeters, Robin P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08) : 3204 - 3211
  • [37] Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease
    Barb, Diana
    Repetto, Enrico M.
    Stokes, Michael E.
    Shankar, Sudha S.
    Cusi, Kenneth
    [J]. OBESITY, 2021, 29 (11) : 1950 - 1960
  • [38] Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes
    Barb, Diana
    Bril, Fernando
    Kalavalapalli, Srilaxmi
    Cusi, Kenneth
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (08) : 3327 - 3336
  • [39] An assessment by the Statin Liver Safety Task Force: 2014 update
    Bays, Harold
    Cohen, David E.
    Chalasani, Naga
    Harrison, Stephen A.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2014, 8 (03) : S47 - S57
  • [40] Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
    Bazick, Jessica
    Donithan, Michele
    Neuschwander-Tetri, Brent A.
    Kleiner, David
    Brunt, Elizabeth M.
    Wilson, Laura
    Doo, Ed
    Lavine, Joel
    Tonascia, James
    Loomba, Rohit
    [J]. DIABETES CARE, 2015, 38 (07) : 1347 - 1355
12345678910